Acadia Healthcare (NASDAQ:ACHC) Lowered to “Sell” at StockNews.com

StockNews.com downgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research note released on Friday.

A number of other research analysts have also recently issued reports on the stock. Mizuho lowered their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a neutral rating for the company in a research report on Friday. Bank of America dropped their price target on Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a research report on Thursday. TheStreet raised Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. Barclays lowered their price objective on Acadia Healthcare from $100.00 to $91.00 and set an overweight rating for the company in a research note on Thursday. Finally, Royal Bank of Canada reissued an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average price target of $89.50.

Acadia Healthcare Stock Down 0.9 %

Acadia Healthcare stock traded down $0.61 during trading hours on Friday, hitting $66.12. 1,213,590 shares of the stock traded hands, compared to its average volume of 674,056. Acadia Healthcare has a one year low of $64.74 and a one year high of $87.77. The company has a market cap of $6.11 billion, a PE ratio of -472.25, a PEG ratio of 1.97 and a beta of 1.31. The firm’s 50-day moving average price is $76.77 and its two-hundred day moving average price is $77.52. The company has a current ratio of 1.27, a quick ratio of 0.67 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm’s revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.75 earnings per share. On average, research analysts forecast that Acadia Healthcare will post 3.56 EPS for the current year.

Insider Activity at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is available through this link. 2.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently made changes to their positions in ACHC. Headlands Technologies LLC bought a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $25,000. GAMMA Investing LLC bought a new stake in Acadia Healthcare during the fourth quarter valued at about $26,000. Mather Group LLC. purchased a new stake in Acadia Healthcare in the first quarter worth about $48,000. Fifth Third Bancorp lifted its position in shares of Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.